Ad-ISF35

· Memgen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ad-ISF35, covering 2015-11-20 to 2015-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]

See pricing